Endonucleases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9422595
APP PUB NO 20140370514A1
SERIAL NO

14377013

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an endonuclease I or enzymatically active fragment thereof wherein said endonuclease I has the sequence of SEQ ID No. 4 or a sequence which is at least 70% identical thereto and wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a residue which is negatively charged as well as nucleic acid molecules encoding these enzymes and methods of removing contaminating polynucleotides from a sample using these enzyme.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOTEC PHARMACON ASA9008 TROMSÖ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Altermark, Bjørn Tromsø, NO 3 1
Havdalen, Linda Tromsø, NO 2 1
Helland, Ronny Tromsdalen, NO 2 1
Lanes, Olav Tromsø, NO 12 39
Leiros, Ingar Tromsø, NO 2 1
Lorentzen, Marit Krokelvdalen, NO 2 1
Solstad, Terese Kvaløysletta, NO 7 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00